Chemours (CC) SEC Filings & 10K Form

$28.43
+0.93 (+3.38%)
(As of 04:00 PM ET)

Recent Chemours SEC Filings

DateFilerForm TypeView
04/25/2024
4:25 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:06 PM
Chemours (Filer)
Form DEF 14A
04/11/2024
3:08 PM
Chemours (Filer)
Form DEFA14A
04/11/2024
3:09 PM
Chemours (Filer)
Form ARS
04/01/2024
4:49 PM
Chemours (Issuer)
Picho Diane I. (Reporting)
Form 3/A
03/29/2024
3:06 PM
Abbott Matthew S (Reporting)
Chemours (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:07 PM
Chemours (Issuer)
Scarborough Alvenia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:13 PM
Chemours (Issuer)
Picho Diane I. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2024
4:30 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
5:04 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
8:28 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:32 PM
Chemours (Issuer)
Scarborough Alvenia (Reporting)
Form 4/A
03/05/2024
6:05 PM
Chemours (Issuer)
Familiar Calderon Gerardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:07 PM
Chemours (Issuer)
Martinko Joseph T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:07 PM
Chemours (Issuer)
Scarborough Alvenia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:08 PM
Chemours (Issuer)
Wellman Kristine M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
7:14 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:17 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:19 AM
Chemours (Filer)
Form NT 10-K
02/16/2024
3:16 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:17 PM
Chemours (Filer)
Form 8-K/A
02/16/2024
9:15 AM
Chemours (Subject)
CRAWFORD CURTIS J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
3:19 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
7:50 AM
Chemours (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Chemours (Subject)
Form SC 13G/A
01/03/2024
3:12 PM
Chemours (Issuer)
Rogers Sandra Phillips (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:26 PM
Chemours (Issuer)
Cowan Alister (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
12:08 PM
Chemours (Issuer)
Cowan Alister (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2023
5:49 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:11 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:45 PM
Charles Ron Christopher (Reporting)
Chemours (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
3:45 PM
Chemours (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2023
3:45 PM
Chemours (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
3:20 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
6:53 PM
Charles Ron Christopher (Reporting)
Chemours (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/03/2023
6:38 PM
Chemours (Issuer)
Rogers Sandra Phillips (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:39 PM
Chemours (Issuer)
Kane Erin N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
10:54 AM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
2:50 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
2:44 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
2:51 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This 1 Biotech Stock has been shocking the markets (Ad)

Save the Date: BioStem's 2024 Q1 Call Coming Up!

Sign Up for the Live Broadcast here
08/25/2023
4:26 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
12:40 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2023
3:47 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
4:23 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2023
2:39 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2023
2:23 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
4:28 PM
Chemours (Issuer)
Lock Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
4:36 PM
Chemours (Issuer)
Wellman Kristine M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:51 PM
Chemours (Issuer)
Wisel Camela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2023
4:31 PM
Chemours (Issuer)
Martinko Joseph T. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2023
7:04 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
8:01 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
3:11 PM
Chemours (Issuer)
Rogers Sandra Phillips (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:11 PM
Chemours (Issuer)
Kane Erin N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:30 PM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
12:33 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
9:05 AM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2023
9:45 AM
Chemours (Issuer)
Newman Mark (Reporting)
Form 4/A
06/12/2023
8:21 AM
Chemours (Issuer)
Newman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
10:14 AM
Chemours (Subject)
Scarborough Alvenia (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
12:47 PM
Chemours (Subject)
Ralhan Sameer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
1:29 PM
Abbott Matthew S (Reporting)
Chemours (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2023
5:46 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
5:31 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2023
6:48 AM
Chemours (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:CC) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners